Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1996 Jan;89(1):49P–50P. doi: 10.1177/014107689608900114

Favourable outcome of scleroderma renal crisis.

D A Collins 1, S Patel 1, J B Eastwood 1, B E Bourke 1
PMCID: PMC1295644  PMID: 8709086

Abstract

Severe hypertension and rapidly progressive acute renal failure is a well recognized complication of scleroderma, often referred to as the renal crisis, and widely thought to cause irreversible deterioration in renal function. With the advent of angiotensin-converting-enzyme inhibitors (ACE-I) the outlook for patients with this condition has dramatically improved. We report here one such patient.

Full text

PDF
49P

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown E. A., Macgregor G. A., Maini R. N. Failure of captopril to reverse the renal crisis of scleroderma. Ann Rheum Dis. 1983 Feb;42(1):52–53. doi: 10.1136/ard.42.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cannon P. J., Hassar M., Case D. B., Casarella W. J., Sommers S. C., LeRoy E. C. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) 1974 Jan;53(1):1–46. doi: 10.1097/00005792-197401000-00001. [DOI] [PubMed] [Google Scholar]
  3. Chapman P. J., Pascoe M. D., van Zyl-Smit R. Successful use of captopril in the treatment of "scleroderma renal crisis". Clin Nephrol. 1986 Aug;26(2):106–108. [PubMed] [Google Scholar]
  4. DiPette D. J., Daisley S. J., Fragola J. A. Scleroderma crisis: progressive renal failure despite blood-pressure control. Clin Pharm. 1983 Mar-Apr;2(2):179–181. [PubMed] [Google Scholar]
  5. Helfrich D. J., Banner B., Steen V. D., Medsger T. A., Jr Normotensive renal failure in systemic sclerosis. Arthritis Rheum. 1989 Sep;32(9):1128–1134. doi: 10.1002/anr.1780320911. [DOI] [PubMed] [Google Scholar]
  6. Lopez-Ovejero J. A., Saal S. D., D'Angelo W. A., Cheigh J. S., Stenzel K. H., Laragh J. H. Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med. 1979 Jun 21;300(25):1417–1419. doi: 10.1056/NEJM197906213002505. [DOI] [PubMed] [Google Scholar]
  7. Steen V. D., Medsger T. A., Jr, Osial T. A., Jr, Ziegler G. L., Shapiro A. P., Rodnan G. P. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med. 1984 May;76(5):779–786. doi: 10.1016/0002-9343(84)90986-0. [DOI] [PubMed] [Google Scholar]
  8. Traub Y. M., Shapiro A. P., Rodnan G. P., Medsger T. A., McDonald R. H., Jr, Steen V. D., Osial T. A., Jr, Tolchin S. F. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) 1983 Nov;62(6):335–352. doi: 10.1097/00005792-198311000-00001. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES